Search

Etamsylate Injection 250mg/2ml (SCOTYLATE 250mg/2ml)

Etamsylate Injection 250 mg/2 ml (SCOTYLATE) is a prescription injectable formulation supplied in 2 ml ampoules for IV/IM administration. Ready product available—order now from Scotmed Care with supply supported through a certified WHO-GMP manufacturing plant.

Product Highlights

  • Composition: Etamsylate Injection 250 mg/2 ml
  • Brand Name: SCOTYLATE
  • Pack: 10 × 2 ml Ampoules
  • Administration: IV / IM
  • Critical-care injectable formulation
  • Ready product available for order
  • Suitable for hospital, institutional and pharmaceutical supply
  • Bulk business enquiries accepted
  • Supply supported through a certified WHO-GMP manufacturing plant
  • Prescription medicine for professional/medical use

SCOTYLATE is formulated to address excessive bleeding and hemorrhagic conditions. This sterile injectable contains etamsylate, a hemostatic agent that promotes blood clotting and reinforces capillary walls. It is used to manage bleeding associated with conditions such as abnormal blood loss during periods and dysfunctional uterine bleeding, ensuring effective hemostasis.

GENRIC NAME:- Etamsylate Injection SCOTYLATE 250mg/2ml For Intramuscular Use (IM)
PACKING:- 10x2ml Ampoules

Etamsylate Injection 250 mg/2 ml (SCOTYLATE) is a prescription injectable formulation supplied in 2 ml ampoules for IV/IM administration. Ready product available—order now from Scotmed Care with supply supported through a certified WHO-GMP manufacturing plant.

Etamsylate Injection 250 mg/2 ml (SCOTYLATE) is a critical-care injectable product from Scotmed Care (P) Limited. Each 2 ml ampoule contains Etamsylate 250 mg, and the product is presented in a pack of 10 × 2 ml ampoules. As shown on the product packaging, it is intended for intravenous (IV) or intramuscular (IM) administration.

Etamsylate is a haemostatic medicine used under medical supervision in clinical situations where control or prevention of capillary bleeding is required. Administration, dosage, treatment duration, and patient selection should always be determined by a qualified healthcare professional.

Ready product is available for order for pharmaceutical distribution, hospital supply, institutional requirements, and bulk business enquiries. Scotmed Care focuses on dependable critical-care pharmaceutical supply with manufacturing support from a certified WHO-GMP plant.

For buyers searching for an Etamsylate Injection manufacturer, Etamsylate Injection supplier in India, Etamsylate 250 mg/2 ml injection, critical care injection company, injectable medicine supplier, or WHO-GMP pharmaceutical manufacturer, SCOTYLATE offers a ready-stock option for professional pharmaceutical procurement.

Pack Size: 10 × 2 ml Ampoules
Composition: Etamsylate 250 mg/2 ml
Dosage Form: Injection
Route: IV / IM
Brand: SCOTYLATE
Availability: Ready product available – Order now
Prescription Status: Rx medicine; for use under medical supervision.

Product Highlights

  • Composition: Etamsylate Injection 250 mg/2 ml
  • Brand Name: SCOTYLATE
  • Pack: 10 × 2 ml Ampoules
  • Administration: IV / IM
  • Critical-care injectable formulation
  • Ready product available for order
  • Suitable for hospital, institutional and pharmaceutical supply
  • Bulk business enquiries accepted
  • Supply supported through a certified WHO-GMP manufacturing plant
  • Prescription medicine for professional/medical use

Content missing

Scroll to Top